MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-31-2025
Laboratory Corporation of America Holdings Total Liabilities 2011-2026 | LH
Annual Total Liabilities Laboratory Corporation of America Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3 B | 8.83 B | 10 B | 10.1 B | 10.7 B | 10.5 B | 9.21 B | 9.74 B | 8.74 B | 9.28 B | 4.48 B | 4.47 B | 4.08 B | 3.61 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 B | 3.61 B | 8.15 B |
Quarterly Total Liabilities Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.55 B | 9.57 B | 9.28 B | 10.3 B | 10.4 B | 8.69 B | 8.56 B | 8.83 B | 8.99 B | 8.91 B | 9.84 B | 10 B | 9.71 B | - | 9.99 B | 10.1 B | 10.3 B | 10.2 B | 10.4 B | 10.6 B | 10.7 B | 10.7 B | 10.7 B | 10.5 B | 10.5 B | 10.5 B | 10.5 B | 9.19 B | 9.19 B | 9.19 B | 9.19 B | 9.85 B | 9.85 B | 9.85 B | 9.85 B | 8.73 B | 8.73 B | 8.73 B | 8.73 B | 9.14 B | 9.2 B | 9.22 B | 9.22 B | 4.46 B | 4.46 B | 4.46 B | 4.46 B | 4.46 B | 4.46 B | 4.46 B | 4.46 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.59 B | 3.61 B | 3.61 B | 3.61 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.7 B | 3.59 B | 8.14 B |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
14.4 M | $ 23.39 | 5.79 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 22.72 | 1.59 % | $ 246 M |  China |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.6 | - | $ 2.03 M | USA |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 40.03 | -1.43 % | $ 1.11 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
9.31 M | $ 6.05 | 0.33 % | $ 178 M | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 12.31 | 1.52 % | $ 349 M | Israel |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 27.91 | -0.36 % | $ 844 M | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 236.45 | 0.37 % | $ 173 B | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
DexCom
DXCM
|
4.2 B | $ 67.5 | -3.71 % | $ 26.1 B | USA |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
3.53 B | $ 101.75 | 0.11 % | $ 18.9 B | USA |
 |
CareDx, Inc
CDNA
|
205 M | $ 17.67 | -6.51 % | $ 950 M | USA |
 |
Celcuity
CELC
|
130 M | $ 106.33 | -2.61 % | $ 4.19 B | USA |
 |
Anixa Biosciences
ANIX
|
2.7 M | $ 3.32 | 1.22 % | $ 106 K | USA |
 |
Guardant Health
GH
|
1.63 B | $ 109.37 | -0.51 % | $ 13.4 B | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
20.8 B | $ 243.24 | -0.43 % | $ 44.1 B | USA |
 |
Illumina
ILMN
|
2.7 B | $ 147.43 | -1.81 % | $ 23.4 B | USA |
 |
Charles River Laboratories International
CRL
|
4.02 B | $ 216.58 | -0.32 % | $ 11.1 B | USA |
 |
Mettler-Toledo International
MTD
|
3.37 B | $ 1 476.11 | 0.4 % | $ 31.3 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
326 M | $ 6.51 | -1.89 % | $ 590 M | USA |
 |
National Research Corporation
NRC
|
73.5 M | $ 19.34 | 2.33 % | $ 475 M | USA |
 |
Natera
NTRA
|
689 M | $ 238.34 | -6.31 % | $ 23.5 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 177.53 | -0.38 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
76.4 M | $ 5.85 | -1.85 % | $ 759 M | USA |
 |
OPKO Health
OPK
|
835 M | $ 1.36 | -0.37 % | $ 944 M | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 189.24 | -6.74 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.7 B | $ 706.32 | -1.15 % | $ 58.2 B | USA |
 |
Lantheus Holdings
LNTH
|
892 M | $ 69.55 | 0.26 % | $ 4.81 B | USA |
 |
Agilent Technologies
A
|
5.32 B | $ 146.93 | -0.59 % | $ 44.7 B | USA |
 |
Biomerica
BMRA
|
1.84 M | $ 2.79 | 0.36 % | $ 6.41 M | USA |
 |
Bioventus
BVS
|
590 M | $ 7.77 | 2.04 % | $ 487 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1.83 M | - | - | $ 9.42 M | Israel |
 |
Koninklijke Philips N.V.
PHG
|
16.9 B | $ 29.53 | 1.46 % | $ 20 B |  Niderland |